No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
| Active immunization against varicella zoster |
|---|
|
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
No information available on dose adjustment in renal impairment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Live attenuated vaccines (e.g., varicella zoster vaccine) should not be given to infants exposed to infliximab in utero until 12 months after birth. Administration of a live attenuated vaccine to a breastfed infant while the mother is receiving infliximab is not recommended unless serum levels of infliximab are undetectable in the infant. These infants may be at increased risk of infection, including severe disseminated infection that can become fatal. [DHPC]
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
| Encephalitis vaccines | ||
|---|---|---|
| J07BA02 | ||
| J07BA01 | ||
| Influenza vaccines | ||
|---|---|---|
| J07BB02 | ||
| Hepatitis vaccines | ||
|---|---|---|
| J07BC20 | ||
| J07BC02 | ||
| J07BC01 | ||
| Measles vaccines | ||
|---|---|---|
| J07BD52 | ||
| Poliomyelitis vaccines | ||
|---|---|---|
| J07BF03 | ||
| Rabies vaccines | ||
|---|---|---|
| J07BG01 | ||
| Rota virus diarrhea vaccines | ||
|---|---|---|
| J07BH01 | ||
| Yellow fever vaccines | ||
|---|---|---|
| J07BL01 | ||
| Papillomavirus vaccines | ||
|---|---|---|
| J07BM03 | ||
| J07BM02 | ||
| Other viral vaccines | ||
|---|---|---|
| J07BX04 | ||
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.